Skip to content
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Publication Details
AFRICAN RESEARCH NEXUS
SHINING A SPOTLIGHT ON AFRICAN RESEARCH
medicine
Protecting the most vulnerable: Tuberculosis in immunocompromised individuals
ERS Monograph, Volume 2023, No. 101, Year 2023
Notification
URL copied to clipboard!
Description
The interaction of Mycobacterium tuberculosis with components of the innate and acquired immune system has significant implications for the clinical outcome of infection (clearance, latency or progression to active disease). Thus, the risk of progressing from LTBI to active TB is greater in some populations. Understanding which populations are at increased risk of TBI and of TB disease is essential to understand who we should screen and treat for TBI. In the past decades, much new knowledge on epidemiology, risk factors and treatment of TBI has been gathered, which is summarised in this chapter. © ERS 2023.
Authors & Co-Authors
Torrado, Egídio
Portugal, Braga
Universidade do Minho
van Crevel, Reinout
Netherlands, Nijmegen
Radboud University Medical Center
Duarte, R. A.B.
Portugal, Porto
Universidade do Porto
Portugal, Vila Nova de Gaia
Centro Hospitalar de Vila Nova de Gaia
Statistics
Authors: 3
Affiliations: 4
Identifiers
Doi:
10.1183/2312508X.10025422
ISSN:
2312508X
Research Areas
Infectious Diseases